Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...
Biodesix Partners With Vanderbilt to Develop Lung Cancer Risk Test Combining Blood Tests and Imaging
Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.
A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results